nach oben

Diabetology International

Erschienen in:

01.03.2021 | Review Article

Understanding the quality of diabetes care in Japan: a systematic review of the literature

verfasst von: Joanna Mitri, Takehiro Sugiyama, Hirokazu Tanaka, Mitsuru Ohsugi, Robert A. Gabbay

Erschienen in: Diabetology International | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Among chronic diseases, diabetes is a frequent focus of performance measurement. Disease-specific indicators based on evidence-based clinical guidelines have been used to evaluate the quality of care. There are worldwide efforts to improve the quality of diabetes care. Measuring the gap is an essential first step toward improving the quality of care.

Methods

In order to better understand the status of quality of diabetes care in Japan, a country with a universal healthcare system, we performed a literature search looking for all studies reporting on quality indicators. In this review, we summarized the studies that have looked at the status of the quality of diabetes care over the last decade.

Results

There were a total of 6 studies that reported on process including HbA1c, blood pressure, lipid screening, retinopathy and nephropathy screening and intermediate clinical measures which included percentages of patients reaching targets for HbA1c, blood pressure and LDL-C. Overall, the process measures continue to improve, however the clinical intermediate outcome measures remain suboptimal.

Conclusion

Despite the improvement in diabetes related process measures, there is limited data on clinical measures. It is necessary to shed more light on the assessment of the quality of diabetes care.

Ali MK, Bullard KM, Gregg EW. Achievement of goals in U.S. Diabetes Care, 1999–2010. N Engl J Med. 2013;18:369(3):287–8.

International Diabetes Federation Guideline Development G. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104(1):1–52.

Introduction: <em>Standards of medical care in diabetes—2020</em>. Diabetes Care. 2020;43(Supplement 1):S1-S2.

Araki E, Goto A, Kondo T, et al. Japanese clinical practice guideline for diabetes 2019. Diabetol Int. 2020;11(3):165–223.CrossRef

International Diabetes Federation. Available at https://idf.org/our-network/regions-members/western-pacific/members/105-japan.html. Accessed on September 3rd, 2020.

Ministry of Health, Labour and Welfare. National Health and Nutrition Survey. Available at https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/h30-houkoku_00001.html. [in Japanese] [accessed on July 16th, 2020].

International Diabetes Federation. Available at https://diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf. Accessed on September 3rd, 2020.

Rivera-Hernandez M, Leyva B, Keohane LM, et al. Quality of care for white and hispanic medicare advantage enrollees in the united states and puerto rico. JAMA Intern Med. 2016;176(6):787–94.CrossRef

Stone MA, Charpentier G, Doggen K, et al. Quality of care of people with type 2 diabetes in eight European countries: findings from the guideline adherence to enhance care (GUIDANCE) study. Diabetes Care. 2013;36(9):2628–38.CrossRef

10.

Du Y, Heidemann C, Schaffrath Rosario A, et al. Changes in diabetes care indicators: findings from German National Health Interview and Examination Surveys 1997–1999 and 2008–2011. BMJ Open Diabetes Res Care. 2015;3(1):e000135.CrossRef

11.

Ikegami N, Yoo BK, Hashimoto H, et al. Japanese universal health coverage: evolution, achievements, and challenges. Lancet. 2011;378(9796):1106–15.CrossRef

12.

Haneda M, Noda M, Origasa H, et al. Japanese Clinical Practice Guideline for Diabetes 2016. J Diabetes Investig. 2018.

13.

American Diabetes A. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S66–S76.

14.

National Heart and Lung Institute. Available at https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed on September 3rd, 2020

15.

Tomio J, Toyokawa S, Tanihara S, et al. Quality of care for diabetes patients using National Health Insurance claims data in Japan. J Eval Clin Pract. 2010;16(6):1164–9.CrossRef

16.

Tanaka H, Tomio J, Sugiyama T, et al. Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan. BMJ Open Diabetes Res Care. 2016;4(1):e000291.CrossRef

17.

Yokoyama H, Oishi M, Takamura H, et al. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40). BMJ Open Diabetes Res Care. 2016;4(1):e000294.CrossRef

18.

Tanaka H, Sugiyama T, Ihana-Sugiyama N, et al. Changes in the quality of diabetes care in Japan between 2007 and 2015: A repeated cross-sectional study using claims data. Diabetes Res Clin Pract. 2019;149:188–99.CrossRef

19.

Sugiyama T, Imai K, Ihana-Sugiyama N, et al. Variation in process quality measures of diabetes care by region and institution in Japan during 2015–2016: An observational study of nationwide claims data. Diabetes Res Clin Pract. 2019;155:107750.CrossRef

20.

Ozaki M, Matsumura S, Iwamoto M, et al. Quality of primary care provided in community clinics in Japan. J Gen Fam Med. 2019;20(2):48–54.CrossRef

21.

Funatsu H, Hori S, Shimizu E, et al. Questionnaire survey on periodic ocular examination in Japanese diabetic patients. Am J Ophthalmol. 2003;136(5):955–7.CrossRef

22.

Hidaka H, Terada M, Maegawa H, et al. Evaluation of a new care system provided to diabetic patients in the outpatient clinic. Intern Med. 2000;39(10):783–7.CrossRef

23.

Andary R, Fan W, Wong ND. Control of cardiovascular risk factors among US adults with type 2 diabetes with and without cardiovascular disease. Am J Cardiol. 2019;124(4):522–7.CrossRef

24.

Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005;83(3):457–502.CrossRef

25.

Hayashino Y, Suzuki H, Yamazaki K, et al. A cluster randomized trial on the effect of a multifaceted intervention improved the technical quality of diabetes care by primary care physicians: The Japan Diabetes Outcome Intervention Trial-2 (J-DOIT2). Diabet Med. 2016;33(5):599–608.CrossRef

26.

Idler EL, Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav. 1997;38(1):21–37.CrossRef

27.

Kleefstra N, Landman GW, Houweling ST, et al. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care. 2008;31(5):932–3.CrossRef

28.

Schmitt A, Reimer A, Kulzer B, et al. Assessment of diabetes acceptance can help identify patients with ineffective diabetes self-care and poor diabetes control. Diabet Med. 2014;31(11):1446–51.CrossRef

29.

Schmitt A, Reimer A, Kulzer B, et al. Negative association between depression and diabetes control only when accompanied by diabetes-specific distress. J Behav Med. 2015;38(3):556–64.CrossRef

30.

Hayashino Y, Okamura S, Tsujii S, et al. Association between diabetes distress and all-cause mortality in Japanese individuals with type 2 diabetes: a prospective cohort study (Diabetes Distress and Care Registry in Tenri [DDCRT 18]). Diabetologia. 2018 2018/09/01;61(9):1978–1984.

31.

Hayashino Y, Okamura S, Tsujii S, et al. Predictive Validity of Each Item of the 8-Item Short-Form Health Survey for All-Cause Mortality in Japanese patients with type 2 diabetes: A prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT 19]). Exp Clin Endocrinol Diabetes. 2019.

32.

Asia Pacific Observatory on Health Systems and Policies.vol. 8(1) (2018). Available at http://www.searo.who.int/entity/asia_pacific_observatory/publications/hits/hit_japan/en/. Accessed 17 July 2019.

33.

Eggleston K, Chen BK, Chen C-H, et al. Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems. Eurpean J Health Econom. 2020 2020/07/01;21(5):689–702.

Titel: Understanding the quality of diabetes care in Japan: a systematic review of the literature
verfasst von: Joanna Mitri
Takehiro Sugiyama
Hirokazu Tanaka
Mitsuru Ohsugi
Robert A. Gabbay
Publikationsdatum: 01.03.2021
Verlag: Springer Singapore
Erschienen in: Diabetology International / Ausgabe 1/2022
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-021-00497-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

A case of α-chain variant hemoglobin (Hb Chad) with falsely high HbA1c levels measured by immunoassay

Cut-off values and clinical efficacy of body roundness index and other novel anthropometric indices in identifying metabolic syndrome and its components among Southern-Indian adults

Tailored notification encouraging examinees with abnormal glucose levels in health checkups to seek medical care

Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial

Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes

Formation of large abscess tumor including gallstone in ileum during therapy for hyperosmolar hyperglycemic syndrome: a case report